Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

SHPAX vs. SHPCX: which is better?

Bottom line

SHPAX vs SHPCX: the short answer

SHPAX and SHPCX are two share classes of the same fund — Health & Biotechnology Portfolio — so they hold the identical portfolio. The differences are cost, minimums and how you buy them.

SHPAX is cheaper at 3% vs 3.6% — a difference of $60 a year per $10,000 invested.

Over five years, SHPCX returned +3.7% a year vs +3.1% for SHPAX.

SHPAX has a front-end sales load of up to 5.75%; the other does not.

Updated Nov 19, 2026

SHPAX vs SHPCX side by side

SHPAXSHPCX
TypeMutual fundMutual fund
Fund familySaratoga AdvantageSaratoga Advantage
CategoryTechnology SectorTechnology Sector
Expense ratio3%3.6%
Annual cost per $10k$300$360
10-yr cost on $10k (prospectus)$3,702$3,862
Max front load5.75%0%
12b-1 fee——
1-yr return−5.5%−1.3%
5-yr return (annualized)+3.1%+3.7%
10-yr return (annualized)+4.1%+4.1%
Best quarter+15.0%+15.0%
Worst quarter−13.0%−13.0%
Net assets (fund)$10.5M$10.5M
Number of holdings2929
Portfolio turnover22%22%
Returns as ofDec 31, 2024Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearSHPAXSHPCXDifference
2024+0.3%−0.3%+0.6%
2023−0.4%−0.9%+0.6%
2022+2.0%+1.4%+0.6%
2021+16.7%+16.0%+0.7%
2020+3.6%+3.0%+0.6%
2019+16.2%+15.4%+0.8%
2018−5.5%−6.0%+0.5%
2017+12.0%+11.3%+0.7%
2016−2.0%−2.5%+0.5%
2015+6.9%+6.3%+0.7%

Source: Fund prospectus bar charts

FAQ

What is the difference between SHPAX and SHPCX?
SHPAX and SHPCX are two share classes of the same fund — Health & Biotechnology Portfolio — so they hold the identical portfolio. The differences are cost, minimums and how you buy them. SHPAX is cheaper at 3% vs 3.6% — a difference of $60 a year per $10,000 invested.
Which is cheaper, SHPAX or SHPCX?
SHPAX has the lower expense ratio (3%).
Should I own both SHPAX and SHPCX?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.